Patients’ perception of proton pump inhibitors use and their risks

doi:10.5306/wjco.v17.i1.113463

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

(38)

(43)

(0)

(833)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Oncol. Jan 24, 2026; 17(1): 113463
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113463

Full Size Figure Download Figure

Figure 2 Quality of life and anxiety symptoms (yes) by proton pump inhibitor type. A: Quality of life by proton pump inhibitor (PPI) type; B: Anxiety symptoms (yes) by PPI type.

Citation: Sawaied IO, Samson AO, Golan E. Patients’ perception of proton pump inhibitors use and their risks. World J Clin Oncol 2026; 17(1): 113463
URL: https://www.wjgnet.com/2218-4333/full/v17/i1/113463.htm
DOI: https://dx.doi.org/10.5306/wjco.v17.i1.113463

Sawaied IO, Samson AO, Golan E. Patients’ perception of proton pump inhibitors use and their risks. World J Clin Oncol 2026; 17(1): 113463 [PMID: 41608350 DOI: 10.5306/wjco.v17.i1.113463]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.